Wolfgang tilgen (48 risultati)

Hardcover. Condizione: Very Good. 3540434682. Hardcover, from closed pharmaceutical company library, light corner wear. Lending record shows this book has never been borrowed. 255 pages, index, illustrated with charts, tables and diagrams. The clinical utility of drug response assays has been evaluated in clinical trials and the results suggest that assay-assisted therapy selection may improve survival as well as economic outcomes. This volume comprises the proceedings of the first Symposium of the International Society for Chemosensitivity Testing in Oncology, ISCO-1, held in Homburg/Saar, Germany, in September 2001. Topics include: new in vitro drug-testing methods, tumor chemosensitivity assays, and the clinical relevance of assay-directed therapy. Contents clean, tight and bright. Book.…

2003th ed. 17 x 23 cm. 255 pages. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.

Condizione: New.

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past 50 years many in vitro and in vivo drug response assay systems have been developed to determine the potential - tivity of chemotherapy agents. The idea was to eliminate ineffective agents and unnecessary toxic treatment while selecting drugs active in vitro or in the mouse model that might increase the probability of response in the patient. None of these test models, however, achieved routine clinical application in the past. This might be at least in part - lated to large discrepancies that were described between the s- cess rate of the assay systems and the clinical benefit in cancer - tients. The heterogeneity of chemosensitivity that exists between different tumors as well as between individual tumor lesions may be one explanation for these findings. Furthermore, different assay end points such as proliferation, metabolism, and vitality were - veloped to evaluate the effects of cytostatic drugs on tumor cells, and these might be related to the differing results. However, knowledge about procedures for assay-assisted treatment selection has increased rapidly within the past few years, and several studies suggest that test-directed chemotherapy selection now may - prove response rates and survival in various types of tumors. The International Society for Chemosensitivity Testing in - cology (ISCO) was founded to promote, coordinate, and improve clinical and laboratory research in the field of predictive drug te- ing in human tumor cells.…

Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past 50 years many in vitro and in vivo drug response assay systems have been developed to determine the potential - tivity of chemotherapy agents. The idea was to eliminate ineffective agents and unnecessary toxic treatment while selecting drugs active in vitro or in the mouse model that might increase the probability of response in the patient. None of these test models, however, achieved routine clinical application in the past. This might be at least in part - lated to large discrepancies that were described between the s- cess rate of the assay systems and the clinical benefit in cancer - tients. The heterogeneity of chemosensitivity that exists between different tumors as well as between individual tumor lesions may be one explanation for these findings. Furthermore, different assay end points such as proliferation, metabolism, and vitality were - veloped to evaluate the effects of cytostatic drugs on tumor cells, and these might be related to the differing results. However, knowledge about procedures for assay-assisted treatment selection has increased rapidly within the past few years, and several studies suggest that test-directed chemotherapy selection now may - prove response rates and survival in various types of tumors. The International Society for Chemosensitivity Testing in - cology (ISCO) was founded to promote, coordinate, and improve clinical and laboratory research in the field of predictive drug te- ing in human tumor cells.…

Condizione: New. pp. 256.

Paperback. Condizione: Brand New. reprint edition. 256 pages. 9.25x6.10x0.58 inches. In Stock.

Hardcover. Condizione: Brand New. 1st edition. 245 pages. 9.25x6.50x0.50 inches. In Stock.

Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Die praxisnahe Fortbildung auf dem Gebiet der operativen und onkologischen Dermatologie zieht sich als roter Faden durch diesen Band. Qualitätssicherung und Erfolgskontrolle haben zu einem hohen Standard der chirurgischen Tätigkeit im Fachbereich Dermatologie in den letzten Jahren geführt.…

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Condizione: As New. Unread book in perfect condition.

Condizione: New.

Paperback. Condizione: Brand New. reprint edition. 420 pages. German language. 9.50x6.80x0.90 inches. In Stock.

Taschenbuch. Condizione: Neu. Operative und konservative Dermato-Onkologie | Neue Ansätze und Strategien | Detlef Petzoldt (u. a.) | Taschenbuch | xxxii | Deutsch | 2011 | Springer-Verlag GmbH | EAN 9783642793370 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.…

Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Die malignen Hauttumoren und die Präkanzerosen der Haut werden umfassend auch unter Einschluß der seltenen Tumoren dargestellt. Im Mittelpunkt steht dabei die histologische Diagnosesicherung. Daneben beschreibt das Buch weitere diagnostische Techniken einschließlich der sonographischen Verfahren und der Positronenemissionstomographie in ihrem derzeitigen Stellenwert. Die prognostische Wertigkeit und die Stadieneinteilung aller Tumoren wird behandelt. Der Hauptschwerpunkt liegt auf der Therapie der Hauttumoren. Die operative Therapie ist dabei genauso ausführlich berücksichtigt wie die medikamentöse Therapie einschließlich der Chemotherapeutika und Zytokine sowie die supportiven Therapien. Ein Standardwerk, das dem Leser aktuelles Wissen und genaue Anleitung für sein praktisches Vorgehen bietet.…

Condizione: Gut. Zustand: Gut | Seiten: 679 | Sprache: Deutsch | Produktart: Bücher | Keine Beschreibung verfügbar.

Hardcover. Condizione: gut. 1997. Die malignen Hauttumoren und die Präkanzerosen der Haut werden umfassend auch unter Einbeziehung der seltenen Tumoren behandelt. Die histologische Diagnosesicherung stellt einen Schwerpunkt des Buches dar.Der Hauptschwerpunkt liegt auf der Therapie der Hauttumoren. Die operative Therapie wird dabei genauso umfangreich abgehandelt wie die medikamentösen Behandlungen einschließlich der Chemotherapie und Zytokine.Auch supportive Therapien werden besprochen und der Leser findet genaue Anleitungen für das praktische Vorgehen. In deutscher Sprache. 663 pages. 27,2 x 20 x 3,4 cm. …

Condizione: New. pp. xvi + 663.

Taschenbuch. Condizione: Neu. Dermatologische Onkologie | Claus Garbe (u. a.) | Taschenbuch | xvi | Deutsch | 2011 | Springer | EAN 9783642644801 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

Paperback. Condizione: Brand New. 679 pages. German language. 10.47x7.64x1.50 inches. In Stock.

Condizione: gut. Operative und konservative Dermato-Onkologie In deutscher Sprache. pages.

Condizione: new. Questo è un articolo print on demand.

Condizione: new. Questo è un articolo print on demand.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Over the past 50 years many in vitro and in vivo drug response assay systems have been developed to determine the potential - tivity of chemotherapy agents. The idea was to eliminate ineffective agents and unnecessary toxic treatment while selecting drugs active in vitro or in the mouse model that might increase the probability of response in the patient. None of these test models, however, achieved routine clinical application in the past. This might be at least in part - lated to large discrepancies that were described between the s- cess rate of the assay systems and the clinical benefit in cancer - tients. The heterogeneity of chemosensitivity that exists between different tumors as well as between individual tumor lesions may be one explanation for these findings. Furthermore, different assay end points such as proliferation, metabolism, and vitality were - veloped to evaluate the effects of cytostatic drugs on tumor cells, and these might be related to the differing results. However, knowledge about procedures for assay-assisted treatment selection has increased rapidly within the past few years, and several studies suggest that test-directed chemotherapy selection now may - prove response rates and survival in various types of tumors. The International Society for Chemosensitivity Testing in - cology (ISCO) was founded to promote, coordinate, and improve clinical and laboratory research in the field of predictive drug te- ing in human tumor cells. 256 pp. Englisch.…